For Australian Healthcare Professionals

As a professional, Eisai aims to support you in the treatment of your patients. In this section you will find information, including: Product Information Documents, and Consumer Medicines Informations (CMIs).

If you require further information, please contact Eisai Medical Information at Medinfo_Australia@eisai.net

Please follow the links to find further details of the medicines available in Australia.

Adverse events may also be reported to Eisai Australia Pty Ltd.
email: Safety_Australia@eisai.net
tel: +61 (03) 9832 9100

Oncology

Lenvima^®
lenvatinib Product Information CMI
Halaven^®
eribulin mesilate Product Information CMI
Gliadel^®
carmustine Product Information CMI

Neurology

Fycompa^®
perampanel Product Information CMI
Inovelon^®
rufinamide Product Information CMI
Dayvigo^®
lemborexant Product Information CMI

Lenvima^®, Halaven^®, Gliadel^®, Fycompa^®, Inovelon^®, Dayvigo^® are all registered trademarks of the Eisai Group, whose affiliate company in Australia is Eisai Australia Ltd, Level 2, 437 St Kilda Road, Melbourne VIC, 3004.